Abrika Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $110M

Abrika Pharmaceuticals General Information

Description

Developer of drug delivery technologies. The company manufactures generic pharmaceutical products and proprietary drugs for tablets and capsules. The company's products include pellets, microparticles, coated granules, transmucosal and transdermal delivery.

Contact Information

Website
www.abrika.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 13800 North West 2nd Avenue
  • Suite 190
  • Sunrise, FL 33325
  • United States
+1 (954)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Corporate Office
  • 13800 North West 2nd Avenue
  • Suite 190
  • Sunrise, FL 33325
  • United States
+1 (954)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abrika Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Apr-2007 $110M Completed Generating Revenue
1. Early Stage VC 01-Jan-2005 Completed Startup
To view Abrika Pharmaceuticals’s complete valuation and funding history, request access »

Abrika Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Signet Healthcare Partners Growth/Expansion Minority
To view Abrika Pharmaceuticals’s complete investors history, request access »

Abrika Pharmaceuticals FAQs

  • When was Abrika Pharmaceuticals founded?

    Abrika Pharmaceuticals was founded in 2002.

  • Where is Abrika Pharmaceuticals headquartered?

    Abrika Pharmaceuticals is headquartered in Sunrise, FL.

  • What industry is Abrika Pharmaceuticals in?

    Abrika Pharmaceuticals’s primary industry is Drug Delivery.

  • Is Abrika Pharmaceuticals a private or public company?

    Abrika Pharmaceuticals is a Private company.

  • What is the current valuation of Abrika Pharmaceuticals?

    The current valuation of Abrika Pharmaceuticals is .

  • What is Abrika Pharmaceuticals’s current revenue?

    The current revenue for Abrika Pharmaceuticals is .

  • Who are Abrika Pharmaceuticals’s investors?

    Signet Healthcare Partners has invested in Abrika Pharmaceuticals.

  • When was Abrika Pharmaceuticals acquired?

    Abrika Pharmaceuticals was acquired on 23-Apr-2007.

  • Who acquired Abrika Pharmaceuticals?

    Abrika Pharmaceuticals was acquired by Actavis Generics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process